A systems toxicology approach to the surface functionality control of graphene-cell interactions

Biomaterials

Volumn 35, Issue 4, 2014, Pages 1109-1127

  Chatterjee, Nivedita ^a   Eom, Hyun Jeong ^a   Choi, Jinhee ^a  

^a University of Seoul   (South Korea)

Author keywords

Graphene oxide (GO); Reduced graphene oxide (rGO); Surface oxidation state; Systems toxicology; TGF 1 pathway; TLR4 NFkB pathway

Indexed keywords

GRAPHENE OXIDES; REDUCED GRAPHENE OXIDES (RGO); SURFACE OXIDATIONS; SYSTEMS TOXICOLOGIES; TLR4-NFKB PATHWAY;

CELL MEMBRANES; GENE EXPRESSION; NANOSTRUCTURED MATERIALS; OXIDATION; SURFACE CHEMISTRY;

GRAPHENE;

GRAPHENE; GRAPHENE OXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NANOMATERIAL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL DEATH; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; INNATE IMMUNITY; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAMAN SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY;

GRAPHENE OXIDE (GO); REDUCED GRAPHENE OXIDE (RGO); SURFACE OXIDATION STATE; SYSTEMS TOXICOLOGY; TGFΒ1 PATHWAY; TLR4-NFKB PATHWAY;

ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; DNA DAMAGE; GENE EXPRESSION PROFILING; GENOMICS; GRAPHITE; HEP G2 CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NANOSTRUCTURES; OXIDATIVE STRESS; OXIDES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SURFACE PROPERTIES; SYSTEMS BIOLOGY;

EID: 84888436114     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.108     Document Type: Article

References (51)

1. Sanchez V.C., Jachak A., Hurt R.H., Kane A.B. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol 2012, 25:15-34.
2. Feng L., Liu Z. Graphene in biomedicine: opportunities and challenges. Nanomedicine (Lond) 2011, 6:317-324.
3. Akhavan O., Ghaderi E., Akhavan A. Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials 2012, 33:8017-8025.
4. Liu S., Zeng T.H., Hofmann M., Burcombe E., Wei J., Jiang R., et al. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano 2011, 5:6971-6980.
5. Akhavan O., Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano 2010, 4:5731-5736.
6. Li Y., Liu Y., Fu Y., Wei T., Le Guyader L., Gao G., et al. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials 2012, 33:402-411.
7. Sasidharan A., Panchakarla L.S., Chandran P., Menon D., Nair S., Rao C.N., et al. Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. Nanoscale 2011, 3:2461-2464.
8. Mullick Chowdhury S., Lalwani G., Zhang K., Yang J.Y., Neville K., Sitharaman B. Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials 2013, 34:283-293.
9. Liao K.H., Lin Y.S., Macosko C.W., Haynes C.L. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces 2011, 3:2607-2615.
10. Zhang W., Wang C., Li Z., Lu Z., Li Y., Yin J.J., et al. Unraveling stress-induced toxicity properties of graphene oxide and the underlying mechanism. Adv Mater 2012, 24:5391-5397.
11. Yang K., Gong H., Shi X., Wan J., Zhang Y., Liu Z. Invivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials 2013, 34:2787-2795.
12. Jastrzebska A.M., Kurtycz P., Olszyna A.R. Recent advances in graphene family materials toxicity investigations. JNanopart Res 2012, 14:1320-1341.
13. Chen G.Y., Yang H.J., Lu C.H., Chao Y.C., Hwang S.M., Chen C.L., et al. Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide. Biomaterials 2012, 33:6559-6569.
14. Zhou H., Zhao K., Li W., Yang N., Liu Y., Chen C., et al. The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR- and NF-kappaB-related signaling pathways. Biomaterials 2012, 33:6933-6942.
15. Nel A., Xia T., Meng H., Wang X., Lin S., Ji Z., et al. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res 2013, 46:607-621.
16. Fernando L.P., Kandel P.K., Yu J., McNeill J., Ackroyd P.C., Christensen K.A. Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles. Biomacromolecules 2010, 11:2675-2682.
17. Ferrari A.C., Robertson J. Interpretation of Raman spectra of disordered and amorphous carbon. Phys Rev B 2000, 61:14095-14107.
18. Eda G., Chhowalla M. Chemically derived graphene oxide: towards large-area thin-film electronics and optoelectronics. Adv Mater 2010, 22:2392-2415.
19. Shim S.H., Kim K.T., Lee J.U., Jo W.H. Facile method to functionalize graphene oxide and its application to poly(ethylene terephthalate)/graphene composite. ACS Appl Mater Interfaces 2012, 4:4184-4191.
20. Liu X., Sen S., Liu J., Kulaots I., Geohegan D., Kane A., et al. Antioxidant deactivation on graphenic nanocarbon surfaces. Small 2011, 7:2775-2785.
21. Ren H., Wang C., Zhang J., Zhou X., Xu D., Zheng J., et al. DNA cleavage system of nanosized graphene oxide sheets and copper ions. ACS Nano 2010, 4:7169-7174.
22. Lindberg H.K., Falck G.C., Suhonen S., Vippola M., Vanhala E., Catalan J., et al. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells invitro. Toxicol Lett 2009, 186:166-173.
23. Moretti M., Dell'Omo M., Villarini M., Pastorelli R., Muzi G., Airoldi L., et al. Primary DNA damage and genetic polymorphisms for CYP1A1, EPHX and GSTM1 in workers at a graphite electrode manufacturing plant. BMC Public Health 2007, 7:270.
24. Verma A., Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
25. Mu Q., Su G., Li L., Gilbertson B.O., Yu L.H., Zhang Q., et al. Size-dependent cell uptake of protein-coated graphene oxide nanosheets. ACS Appl Mater Interfaces 2012, 4:2259-2266.
26. Kim Y.W., Park J., Lee H.J., Lee S.Y., Kim S.J. TGF-beta sensitivity is determined by N-linked glycosylation of the type II TGF-beta receptor. Biochem J 2012, 445:403-411.
27. He X., Young S.H., Schwegler-Berry D., Chisholm W.P., Fernback J.E., Ma Q. Multiwalled carbon nanotubes induce a fibrogenic response by stimulating reactive oxygen species production, activating NF-kappaB signaling, and promoting fibroblast-to-myofibroblast transformation. Chem Res Toxicol 2011, 24:2237-2248.
28. Lin Z., Liu L., Xi Z., Huang J., Lin B. Single-walled carbon nanotubes promote rat vascular adventitial fibroblasts to transform into myofibroblasts by SM22-alpha expression. Int J Nanomed 2012, 7:4199-4206.
29. Boudreau H.E., Casterline B.W., Rada B., Korzeniowska A., Leto T.L. Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells. Free Radic Biol Med 2012, 53:1489-1499.
30. Hitoshi K., Katoh M., Suzuki T., Ando Y., Nadai M. Changes in expression of drug-metabolizing enzymes by single-walled carbon nanotubes in human respiratory tract cells. Drug Metab Dispos 2012, 40:579-587.
31. Ji Z., Zhang D., Li L., Shen X., Deng X., Dong L., et al. The hepatotoxicity of multi-walled carbon nanotubes in mice. Nanotechnology 2009, 20:445101.
32. Muller G.F., Dohr O., El-Bahay C., Kahl R., Abel J. Effect of transforming growth factor-beta1 on cytochrome P450 expression: inhibition of CYP1 mRNA and protein expression in primary rat hepatocytes. Arch Toxicol 2000, 74:145-152.
33. Jin M.H., Hong C.H., Lee H.Y., Kang H.J., Han S.W. Enhanced TGF-beta1 is involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced oxidative stress in C57BL/6 mouse testis. Toxicol Lett 2008, 178:202-209.
34. Meyer C., Godoy P., Bachmann A., Liu Y., Barzan D., Ilkavets I., et al. Distinct role of endocytosis for Smad and non-Smad TGF-beta signaling regulation in hepatocytes. JHepatol 2011, 55:369-378.
35. Zhiqing L., Zhuge X., Fuhuan C., Danfeng Y., Huashan Z., Bencheng L., et al. ICAM-1 and VCAM-1 expression in rat aortic endothelial cells after single-walled carbon nanotube exposure. JNanosci Nanotechnol 2010, 10:8562-8574.
36. Wang R.H., Li C., Xu X., Zheng Y., Xiao C., Zerfas P., et al. Arole of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005, 2:399-409.
37. Zhou X., Hu H., Balzar S., Trudeau J.B., Wenzel S.E. MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-beta1 and IL-13 in human airway fibroblasts. JImmunol 2012, 188:6046-6054.
38. Samarakoon R., Chitnis S.S., Higgins S.P., Higgins C.E., Krepinsky J.C., Higgins P.J. Redox-induced Src kinase and caveolin-1 signaling in TGF-beta1-initiated SMAD2/3 activation and PAI-1 expression. PLoS One 2011, 6:e22896.
39. Collins A.R., Ferguson L.R. DNA repair as a biomarker. Mutat Res 2012, 736:2-4.
40. Hartwig A. Role of DNA repair in particle- and fiber-induced lung injury. Inhal Toxicol 2002, 14:91-100.
41. Zhu L., Chang D.W., Dai L., Hong Y. DNA damage induced by multiwalled carbon nanotubes in mouse embryonic stem cells. Nano Lett 2007, 7:3592-3597.
42. Wang M., Saha J., Hada M., Anderson J.A., Pluth J.M., O'Neill P., et al. Novel Smad proteins localize to IR-induced double-strand breaks: interplay between TGFbeta and ATM pathways. Nucleic Acids Res 2013, 41:933-942.
43. Kanamoto T., Hellman U., Heldin C.H., Souchelnytskyi S. Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair. EMBO J 2002, 21:1219-1230.
44. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
45. Furlong H., Mothersill C., Lyng F.M., Howe O. Apoptosis is signalled early by low doses of ionising radiation in a radiation-induced bystander effect. Mutat Res 2013, 741-742:35-43.
46. Zhu Y., Ahlemeyer B., Bauerbach E., Krieglstein J. TGF-beta1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal cultures. Neurochem Int 2001, 38:227-235.
47. Fujita T., Epperly M.W., Zou H., Greenberger J.S., Wan Y. Regulation of the anaphase-promoting complex-separase cascade by transforming growth factor-beta modulates mitotic progression in bone marrow stromal cells. Mol Biol Cell 2008, 19:5446-5455.
48. Noh H., Oh E.Y., Seo J.Y., Yu M.R., Kim Y.O., Ha H., et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol 2009, 297:F729-F739.
49. Moustakas A., Souchelnytskyi S., Heldin C.H. Smad regulation in TGF-beta signal transduction. JCell Sci 2001, 114:4359-4369.
50. Qian Y., Chen X. ID1, inhibitor of differentiation/DNA binding, is an effector of the p53-dependent DNA damage response pathway. JBiol Chem 2008, 283:22410-22416.
51. Song H., Guo B., Zhang J., Song C. Transforming growth factor-beta suppressed Id-1 expression in a smad3-dependent manner in LoVo cells. Anat Rec (Hoboken) 2010, 293:42-47.